Expression of Concern: Atractylon treatment prevents sleep-disordered breathing-induced cognitive dysfunction by suppression of chronic intermittent hypoxia-induced M1 microglial activation

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2023
Materias:
Expression of Concern
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214095/
https://www.ncbi.nlm.nih.gov/pubmed/37218500
http://dx.doi.org/10.1042/BSR-2019-2800_EOC

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214095/
https://www.ncbi.nlm.nih.gov/pubmed/37218500
http://dx.doi.org/10.1042/BSR-2019-2800_EOC

Ejemplares similares